Vivos Therapeutics, Inc. (VVOS)
1.35
-0.06
(-4.26%)
USD |
NASDAQ |
Mar 03, 16:00
1.30
-0.05
(-3.70%)
After-Hours: 20:00
Vivos Therapeutics Free Cash Flow : -15.37M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Celldex Therapeutics, Inc. | -213.66M |
| Plus Therapeutics, Inc. | -15.78M |
| Atossa Therapeutics, Inc. | -26.29M |
| Abeona Therapeutics, Inc. | -82.36M |
| Cell Source, Inc. | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.161M |
| Cash from Investing (Quarterly) | 0.083M |
| Cash from Financing (Quarterly) | 2.763M |
| Free Cash Flow Per Share (Quarterly) | -0.372 |
| Free Cash Flow to Equity (Quarterly) | -4.995M |
| Free Cash Flow to Firm (Quarterly) | -4.078M |
| Free Cash Flow Yield | -131.8% |